Dr. Tayama is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Genentech
1 DNA Way
South San Francisco, CA 94080Phone+1 650-467-3145- Is this information wrong?
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityChief Residency, Internal Medicine, 2008 - 2009
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2006 - 2008
- Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 2005 - 2006
- University of California San Francisco School of MedicineClass of 2005
Certifications & Licensure
- CA State Medical License 2006 - 2024
Publications & Presentations
PubMed
- 20 citationsAtezolizumab in Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: Clinical Experience from an Expanded Access Study in the United StatesSumanta K. Pal, Jean H. Hoffman-Censits, Hanzhe Zheng, Constanze Kaiser, Darren Tayama, Joaquim Bellmunt> ;European Urology. 2018 May 1
- 5 citationsWhat is the value of conducting a trial of r-tPA for the treatment of mild stroke patients?Gregory F. Guzauskas, Er Chen, Deepa Lalla, Elaine W. Yu, Darren Tayama, David L. Veenstra> ;International Journal of Stroke. 2017 Feb 1
- 1 citationsQuality adjusted life year gains associated with administration of recombinant tissue-type plasminogen activator for treatment of acute ischemic stroke: 1998-2011.Deborah P. Lubeck, Mark D. Danese, Jennifer Duryea, Marc Halperin, Darren Tayama, Elaine W. Yu, Deepa Lalla, James C. Grotta> ;International Journal of Stroke. 2016 Jan 18
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: